New York State Teachers Retirement System reduced its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 0.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 276,880 shares of the financial services provider’s stock after selling 1,978 shares during the period. New York State Teachers Retirement System owned approximately 0.08% of CME Group worth $76,314,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of CME. GAMMA Investing LLC lifted its holdings in CME Group by 24.5% in the first quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock valued at $1,859,000 after buying an additional 1,381 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in CME Group by 63.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider’s stock valued at $27,867,000 after buying an additional 40,592 shares during the period. Dynamic Advisor Solutions LLC lifted its holdings in CME Group by 3.1% in the first quarter. Dynamic Advisor Solutions LLC now owns 2,533 shares of the financial services provider’s stock valued at $672,000 after buying an additional 76 shares during the period. Ritholtz Wealth Management increased its stake in CME Group by 10.3% in the first quarter. Ritholtz Wealth Management now owns 4,451 shares of the financial services provider’s stock valued at $1,181,000 after purchasing an additional 416 shares in the last quarter. Finally, Brighton Jones LLC bought a new stake in CME Group in the first quarter valued at approximately $320,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have commented on CME. Barclays lowered their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 8th. UBS Group lowered their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Oppenheimer upped their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Raymond James Financial lowered their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday. Finally, JPMorgan Chase & Co. upped their target price on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $283.71.
Insider Buying and Selling at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 in the last three months. 0.30% of the stock is currently owned by company insiders.
CME Group Stock Up 0.4%
CME stock opened at $268.15 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $96.64 billion, a P/E ratio of 25.96, a P/E/G ratio of 6.13 and a beta of 0.41. The business has a 50-day moving average of $267.96 and a 200-day moving average of $271.30. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.56 earnings per share. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is currently 48.40%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- How to Calculate Inflation Rate
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Invest in Insurance Companies: A Guide
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.